These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1879772)
1. [Pancreatic carcinoma, sex hormones receptors and treatment with tamoxifen]. Grunebaum E; Chaitchuk S; Shoenfeld Y Harefuah; 1991 Mar; 120(6):340-3. PubMed ID: 1879772 [No Abstract] [Full Text] [Related]
2. Breast cancer. The hormone factor. Wissing VS Am J Nurs; 1984 Sep; 84(9):1117-9. PubMed ID: 6566508 [No Abstract] [Full Text] [Related]
3. [Tamoxifen for metastatic pancreatic adenocarcinoma: a complete response]. Lamy R; Conroy T; Brunaud L; Bresler L Gastroenterol Clin Biol; 2001 Oct; 25(10):912-3. PubMed ID: 11852397 [TBL] [Abstract][Full Text] [Related]
4. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma]. Prodi G; Lollini PL; Nicoletti G Minerva Med; 1984 Feb; 75(6):219-21. PubMed ID: 6709205 [No Abstract] [Full Text] [Related]
5. Hormones in chemotherapy for pancreatic cancer, chemoagents or carriers? Siu TO; Kwan WB In Vivo; 1989; 3(4):255-8. PubMed ID: 2519861 [TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [TBL] [Abstract][Full Text] [Related]
8. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. Gelmann EP Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-65-S1-70. PubMed ID: 9045318 [TBL] [Abstract][Full Text] [Related]
9. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma. Crowson MC; Dorrell A; Rolfe EB; Fielding JW Eur J Surg Oncol; 1986 Dec; 12(4):335-6. PubMed ID: 3780986 [TBL] [Abstract][Full Text] [Related]
10. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors. Wittliff JL; Day TG; Dean WL; Allegra JC Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018 [No Abstract] [Full Text] [Related]
11. [Hormonotherapy of cancer of the exocrine pancreas]. Huguier M; Baumel H; Houry S; Lacaine F Gastroenterol Clin Biol; 1990; 14(2):171-4. PubMed ID: 2158471 [No Abstract] [Full Text] [Related]
13. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer. Lundgren S; Søreide JA; Lea OA Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700 [TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513 [TBL] [Abstract][Full Text] [Related]
15. [Determination of cytoplasmic receptors for specific steroid hormones. I) Estrogen receptor]. Nicoletti G; Galli MC; Nanni P; De Giovanni C Boll Soc Ital Biol Sper; 1979 Jan; 55(2):108-12. PubMed ID: 17955632 [No Abstract] [Full Text] [Related]
16. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment. Theve NO; Pousette A; Carlström K Clin Oncol; 1983 Sep; 9(3):193-7. PubMed ID: 6616993 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]